Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
.software
 |  |  |  |  | 


Open AccessSoftware

PEMer: a computational framework with simulation-based error models for inferring genomic structural variants from massive paired-end sequencing data

Jan O Korbel1,2,3 email, Alexej Abyzov3 email, Xinmeng Jasmine Mu4 email, Nicholas Carriero5 email, Philip Cayting3 email, Zhengdong Zhang3 email, Michael Snyder3,4 email and Mark B Gerstein3,4,5,6 email

Gene Expression Unit, European Molecular Biology Laboratory (EMBL), Meyerhofstr., Heidelberg, 69117, Germany

EMBL Outstation Hinxton, EMBL-European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, UK

Molecular Biophysics and Biochemistry Department, Yale University, Whitney Ave, New Haven, CT 06520, USA

Department of Molecular, Cellular, and Developmental Biology, Yale University, Whitney Ave, New Haven, CT 06520, USA

Department of Computer Science, Yale University, Prospect Street, New Haven, CT 06511, USA

Program in Computational Biology and Bioinformatics, Yale University, Whitney Ave, New Haven, CT 06520, USA

author email corresponding author email

Genome Biology 2009, 10:R23doi:10.1186/gb-2009-10-2-r23

Published: 23 February 2009

Subject areas: Bioinformatics, Genome studies

Abstract

Personal-genomics endeavors, such as the 1000 Genomes project, are generating maps of genomic structural variants by analyzing ends of massively sequenced genome fragments. To process these we developed Paired-End Mapper (PEMer; http://sv.gersteinlab.org/pemer webcite). This comprises an analysis pipeline, compatible with several next-generation sequencing platforms; simulation-based error models, yielding confidence-values for each structural variant; and a back-end database. The simulations demonstrated high structural variant reconstruction efficiency for PEMer's coverage-adjusted multi-cutoff scoring-strategy and showed its relative insensitivity to base-calling errors.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.